The U.S. Food and Drug Administration (FDA) could expand emergency use authorization (EUA) for use of the Pfizer/BioNTech Covid-19 mRNA vaccine to those 12 to 15 years of age as early as this coming week.
Pfizer s vaccine emerges on top with 91% efficacy against Covid
With the desperate need for inoculation against COVID-19 gripping the entire world, vaccines have become an integral part of the common lexicon. The Pfizer-BioNTech vaccine is one such example. However, most people are not aware of the intricate and laborious process that goes into its making.
The Pfizer-BioNTech vaccine received emergency use authorization (EUA) in December 2020 from the US Food and Drug Administration (FDA). It was also the first mRNA vaccine to be given a EUA. So how is this vaccine against the notorious SARS-CoV-2 coronavirus made? It is a complex process that spans over 60 days and requires the utilization of resources at multiple facilities located across two countries. Let us take a look at it.